Fonds de Dotation ACTION | ClinicalTrials HQ

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia	Arrhythmias, Cardiac, Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cryptogenic Ischemic Stroke, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, ischemic stroke, nervous system disorder, patent foramen ovale, stroke disorder, vascular disorder	Active, not recruiting	Phase 3	2026-09-09		NCT05213104
Colchicine Versus Placebo in Acute Myocarditis Patients	Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute myocarditis, cardiomyopathy, cardiovascular disorder, heart disorder, myocarditis	Recruiting	Phase 3	2026-02-25		NCT05855746
Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome	Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute coronary syndrome, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder	Recruiting	Phase 3	2026-01-16		NCT05577988